methylthio-adp has been researched along with Astrocytoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haas, M; Reiser, G; Shaaban, A | 1 |
Fam, SR; Gallagher, CJ; Kalia, LV; Salter, MW | 1 |
Calleri, E; Frazier, CR; Massolini, G; Moaddel, R; Wainer, IW | 1 |
Enkvist, E; Järv, J; Kelve, M; Raidaru, G; Sak, K; Subbi, J; Uri, A | 1 |
Barnard, EA; Cousens, DJ; Humphrey, PP; Lundahl, TS; Sellers, LA; Simon, J | 1 |
5 other study(ies) available for methylthio-adp and Astrocytoma
Article | Year |
---|---|
Alanine-(87)-threonine polymorphism impairs signaling and internalization of the human P2Y11 receptor, when co-expressed with the P2Y1 receptor.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Substitution; Astrocytoma; Autoimmunity; Brain; Calcium Signaling; Cell Line, Tumor; Cyclic AMP; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Polymorphism, Single Nucleotide; Protein Interaction Mapping; Purinergic Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Structure-Activity Relationship; Thionucleotides; Transfection | 2014 |
Differential frequency dependence of P2Y1- and P2Y2- mediated Ca 2+ signaling in astrocytes.
Topics: Adenosine Diphosphate; Animals; Astrocytes; Astrocytoma; Biological Clocks; Calcium; Calcium Signaling; Cells, Cultured; Feedback, Physiological; Fluorescent Dyes; Humans; Mutagenesis, Site-Directed; Protein Kinase C; Purinergic P2 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Spectrometry, Fluorescence; Structure-Activity Relationship; Thionucleotides; Uridine Triphosphate | 2003 |
The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening.
Topics: Adenosine Diphosphate; Astrocytoma; Binding Sites; Binding, Competitive; Chromatography, Affinity; Deoxyadenine Nucleotides; Humans; Membranes, Artificial; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Sensitivity and Specificity; Thionucleotides; Transfection; Tumor Cells, Cultured | 2007 |
Adenosine-derived non-phosphate antagonists for P2Y(1) purinoceptors.
Topics: Adenosine; Adenosine Diphosphate; Aspartic Acid; Astrocytoma; Dose-Response Relationship, Drug; Humans; Phosphates; Phosphatidylinositols; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Thionucleotides; Tumor Cells, Cultured | 2000 |
Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Annexin A5; Apoptosis; Astrocytoma; Carbachol; Carbazoles; Chromones; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; ets-Domain Protein Elk-1; GTP-Binding Proteins; Humans; Indoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Morpholines; p38 Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase C; Proto-Oncogene Proteins; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Recombinant Proteins; Thionucleotides; Transcription Factors; Tumor Cells, Cultured; Virulence Factors, Bordetella | 2001 |